US Patent 9416173 Peptide and conjugate vaccines for fungal infections
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+416 characters)
Article
Patent abstract
Several new peptides have been developed that show effectiveness as vaccines against candidiasis and other fungal diseases. A new conjugate vaccine of a β-mannotriose linked to a fungal peptide linked to tetanus toxin has been shown to be effective as a vaccine with or without use of an adjuvant. In addition, a monoclonal antibody has been identified that offers protection from a Candida infection.
Edits on 26 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09416173 Peptide and conjugate vaccines for fungal infections US Patent 9416173 Peptide and conjugate vaccines for fungal infections
Infobox
Patent Number
0941617300
Patent Number
941617300
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
094161730
Date of Patent
August 16, 2016
0Patent Application Number
141125610
Date Filed
April 20, 2012
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
094161730
Date of Patent
August 16, 2016
0Patent Application Number
141125610
Date Filed
April 20, 2012
0Official Website
Patent Primary Examiner
Edits on 5 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Find more entities like US Patent 9416173 Peptide and conjugate vaccines for fungal infections
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
